Stock Taper
SCREENER COMPARE ANY 2 STOCKS
EW
EDWARDS LIFESCIENCES CORPORATION
NYSE
$90.21
▲ UP 0.29% (0.26)

KEY STATISTICS

Market Cap$51.94 B
52w High$96.29
52w Low$72.30
Dividend Yield—
Frequency—
P/E33.41
Volume2.04M
Shares Out.575.80M

COMPANY

LEADERSHIP

Bernard J. Zovighian
CHIEF EXECUTIVE
Bernard J. Zovighian

COMPENSATION 2026

Salary$1,192,500
Stock Awards$7,167,024
Incentive Plan Pay$2,406,537
All Other Comp.$189,085
Total$17,454,255

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 27, 2000
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
16,000

PRICE TARGET

Target High$110.00
Target Low$85.00
Target Median$101.00
Target Consensus$101.70

UPCOMING EARNINGS

DateOct 29, 2026
DayThursday
Rev. Est.$1.68B
OCT
29
THU

SPLIT RECORD

DATETYPERATIO
2020-06-01Forward3:1
2015-12-14Forward2:1
2010-05-28Forward2:1

PRICE

$90.21 ▲ UP 0.29% (+$0.26)
OVERLAYS
$89.75$90.00$90.259:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM90.21

About Edwards Lifesciences Corporation

https://www.edwards.com ↗

Edwards Lifesciences develops innovative products for structural heart disease, critical care, and surgical monitoring, including transcatheter and surgical valve solutions, advanced monitoring systems, and minimally invasive therapies worldwide.

INDUSTRY

Medical - Devices

A PRODUCT EDWARDS LIFESCIENCES CORPORATION IS KNOWN FOR

SAPIEN M3
SAPIEN M3

The SAPIEN M3 is Edwards Lifesciences' first transcatheter mitral valve replacement device for patients with mitral regurgitation ineligible for open surgery, marking a key innovation in minimally invasive structural heart therapies.

COMPETITORS

COMPETITOR
ABT COMPARE
BSX COMPARE
ISRG COMPARE
MDT COMPARE
SYK COMPARE

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Transcatheter Heart Valves$1.15B $1.16B ▲$1.2B ▲$1.26B ▲
Surgical Heart Valve Therapy$258M $253.6M ▼— —
Transcatheter Mitral And Tricuspid Therapies$145.2M $155.7M ▲$175.1M ▲$198.6M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$907.5M $907M ▼$937.6M ▲$1B ▲
Europe$387.9M $409.6M ▲$442.6M ▲$439.6M ▼
Rest Of World— $333.1M — —
JAPAN$90.1M $87.5M ▼$90.6M ▲$96.4M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
967
LISTED HERE
26
RANKED BY POSITION SIZE
VTS.AX
0.07% · 18.3M
XWD.TO
0.06% · 7.7M
SPY
0.08% · 7.1M
RSP
0.20% · 2.2M
JEPI
0.19% · 967.9K
SCHX
0.07% · 614.5K
DFAC
0.07% · 367.7K
XDEW.L
0.20% · 355.1K
BAFE
2.01% · 352.3K
FHLC
0.71% · 276.7K
HMWO.L
0.12% · 261.7K
NULV
0.79% · 250.5K
FWD
0.64% · 229.5K
GSLC
0.12% · 209.1K
WSRUS.SW
0.23% · 182.6K
ZSP.TO
0.08% · 179.1K
WESE.PA
0.27% · 137.0K
SPYI
0.08% · 101.0K
QUAL.AX
0.14% · 98.0K
AVUS
0.06% · 95.0K
SEIQ
0.85% · 68.6K
FTC
0.38% · 57.2K
SSO
0.05% · 52.8K
DOCG.L
1.43% · 52.5K
BKLC
0.08% · 48.6K
SPUS
0.14% · 48.1K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
59.89%
HOLDERS
1,940
TOP 12 OF 1,940 · RANKED BY POSITION SIZE
Vanguard Group Inc
70.4M sh · $5.47B
Blackrock, Inc.
58.8M sh · $5.32B
Blackrock Inc.
51.0M sh · $4.71B
State Street Corp
26.3M sh · $2.38B
Jpmorgan Chase & Co
26.0M sh · $2.22B
Wellington Management Group Llp
22.0M sh · $1.76B
Bank Of New York Mellon Corp
19.0M sh · $1.48B
Fmr LLC
16.6M sh · $1.41B
Geode Capital Management, LLC
15.4M sh · $1.39B
Jennison Associates LLC
14.0M sh · $1.09B
Dz Bank AG Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
13.0M sh · $1.18B
Ninety One Uk Ltd
12.4M sh · $992.68M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity4
Return On Assets4
Debt To Equity3
Price To Earnings1
Price To Book2
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Purchase
2026-05-01
 Josh Gottheimer
Josh Gottheimer
Sale
2025-11-19
 Bruce Westerman
Bruce Westerman
Sale
2025-04-21
 Rob Bresnahan
Rob Bresnahan
Purchase
2025-04-08

INSIDER TRADES

★
OFFICER: CVP, EMEACLA
Bruls Annette
Sale · 2.6K shares
2026-08-28
★
OFFICER: CVP, TMTT, SURGICAL & IHFM
Chopra Daveen
Sale · 31.8K shares
2026-08-26
★
OFFICER: CVP, TMTT, SURGICAL & IHFM
Chopra Daveen
Purchase · 31.8K shares
2026-08-26
★
OFFICER: CVP, TMTT, SURGICAL & IHFM
Chopra Daveen
Sale · 1.2K shares
2026-08-26

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 6
OVERWEIGHT 4
OUTPERFORM 4
HOLD 2
NEUTRAL 2
PEER PERFORM 1
PERFORM 1
20 GRADES IN THE LAST 12 MONTHS
JP Morgan OVERWEIGHT Piper Sandler OVERWEIGHT Leerink Partners OUTPERFORM Truist Securities HOLD Mizuho OUTPERFORM RBC Capital OUTPERFORM Citigroup BUY Evercore ISI Group OUTPERFORM

SECTORS PEERS

PEERPRICE
ARGX$1023.21COMPARE
CAH$234.55COMPARE
BDX$189.52COMPARE
VEEV$276.69COMPARE
HLN$10.11COMPARE
A$153.85COMPARE
ALC$72.01COMPARE
DXCM$90.82COMPARE